What is SkinPen?

SkinPen is the world's first microneedling device cleared by the U.S. Food and Drug Administration (FDA).

Overview

SkinPen, developed by Crown Aesthetics, is an FDA-cleared microneedling device clinically proven to safely and effectively treat facial acne scars in individuals aged 22 and older.

With as few as three non-invasive treatments spaced 30 days apart, patients can achieve improved skin appearance lasting up to six months following the final session, enhancing confidence in daily life.

Features and Benefits

SkinPen generates controlled micro-injuries to activate the body's natural wound-healing process, minimizing cellular damage. This promotes effective remodeling of scar tissue while preserving the skin's overall structure.

Patient Satisfaction

In clinical trials, 90% of participants would recommend SkinPen to friends and family.

Safety Profile

As the first FDA-cleared microneedling device, SkinPen establishes the industry standard for safety.

Suitability

SkinPen is suitable for all skin types.

Recovery

The procedure involves minimal downtime, allowing most patients to resume normal activities within 24 hours.

Clinical Indications

SkinPen is clinically proven to reduce the appearance of acne scars. It is a minimally invasive in-office procedure with a strong safety record, as evidenced by 90% of clinical trial subjects recommending it to others.

Mechanism of Action

SkinPen produces hundreds to thousands of micro-punctures per second, stimulating the skin's natural wound-healing phases—inflammation, proliferation, and remodeling—to facilitate tissue remodeling without inducing scar tissue formation.